%0 Journal Article %T Identifying therapeutic vulnerabilities in lung cancer: application of a chemistry-first approach %A Pine, Sharon R. %A Ryan, BrĂ­d M. %J Translational Lung Cancer Research %D 2018 %B 2018 %9 %! Identifying therapeutic vulnerabilities in lung cancer: application of a chemistry-first approach %K %X In the last three decades, 5-year relative survival rates for lung cancer improved slightly, from 14.3%, 15.5%, and 18.4% (1). One of the reasons for these dismal survival rates is that most patients present with advanced-stage disease, a time during which systemic therapies are unlikely to be curative. %U https://tlcr.amegroups.org/article/view/23934 %P S265-S269 %@ 2226-4477